UCL TINs Industry Club: Enabling life science and technology breakthroughs

Photo 1: Dr Jane Kinghorn, Director of the Translational Research Office, kick-started the roundtable by underscoring the newly-launched UCL TINs Industry Club’s position as a single collaborative platform for industry partners to access the research expertise at UCL.

On 27 June 2024, the UCL Translational Research Office (TRO) organised a roundtable for the newly launched UCL TINs Industry Club - a collaborative platform for companies to access research expertise within UCL’s Therapeutic Innovation Networks (TINs).

The pilot event was attended by six major pharmaceutical companies, UCL scientists, our Expert in Residence, and the TRO team. Together, they identified common R&D challenges related to the therapeutic modality of small molecules and brainstormed how UCL academics can collaborate with industry to tackle unmet  patient needs. The event will pave the way for advancing innovative ideas into collaborative projects and for progressing similar discussions in other therapeutic and diagnostic areas.

UCL TINs Industry Club is built on the Therapeutic Innovation Networks (TINs) initiated by the TRO, which have generated a ‘critical mass’ of research and healthcare innovation expertise from across academia and industry. UCL’s six TINs are modality-focused agglomerations of researchers & other stakeholdersr, based around six of UCL’s core biomedical research strengths :
i) Small Molecules,
ii) Biologics,
iii) Repurposing,
iv) Cell & Gene Therapy,
v) Devices & Diagnostics, and
i) Regenerative Medicine.

The launch of the UCL TINs Industry Club represents a step further in forming a single collaborative platform for industry partners to access the expertise of all six TINs, for the purpose of stimulating collaborations, co-developing challenge-led funding calls, and tackling unmet patient needs.

If you are a UCL researcher or an industry partner interested in getting involved, please contact:
Dr David Collier, Senior Business and Innovation Manager, david.collier@ucl.ac.uk

Prof. Matthew Todd, Professor of Drug Discovery Pharma & Biochemistry and Chair of the Small Molecules TIN, chaired the wrap-up session of the pilot UCL TINs Industry Club Roundtable, inspiring further discussions on the common challenges .

Interested to stay informed of upcoming news, events and funding calls?

• Subscribe to our newsletter and you would automatically become a member of UCL TINs (Therapeutic Innovation Networks) and be the first to receive our event invitations

• Follow us on social media (LinkedIn, Twitter) and stay tuned to our news and updates.